Here s the trailer for Nathan Fielder s Elizabeth Holmes documentary, in theaters October 16

Billy Odell Tucker-Robinson Founder & Host — Banking With Billy Network • Intelligence Network • Data Science • AI Research • World News
Published: 2026-09-23T18:10:46.972Z • Permanent link

Nathan Fielder, the renowned Canadian comedian and writer, is set to release a documentary series about Elizabeth Holmes, the fallen queen of Silicon Valley. The documentary, which will be released in theaters on October 16, promises to delve into the world of Holmes' rise and fall, her rise to prominence as the founder and CEO of Theranos, and the catastrophic consequences that followed. Holmes, who was once hailed as a visionary entrepreneur, was eventually stripped of her titles and freedom after it was discovered that her company's blood-testing technology was fundamentally flawed.

Holmes' story is one of hubris, deception, and the unbridled ambition that can define the world of tech startups. Born in 1984 in Washington, D.C., Holmes was a high-achieving student who attended Stanford University, where she studied psychology and computer science. It was during this time that she began to formulate her vision for Theranos, a company that promised to revolutionize the healthcare industry with its proprietary blood-testing technology. Over the years, Holmes amassed a considerable following, including prominent figures such as Donald Trump and Oprah Winfrey, who invested heavily in her company.

The documentary promises to explore the complex web of relationships that fueled Holmes' rise to power, including her relationships with investors, partners, and even her own family members. Holmes' rise was meteoric, and she quickly became one of the most recognizable and influential figures in the tech world. However, her success was short-lived, and in 2018, it was revealed that her company's technology was fundamentally flawed, leading to a series of devastating consequences, including the loss of millions of dollars in investor funding and the downfall of several prominent partners.

The fallout from Holmes' downfall has had far-reaching consequences for the Global Infrastructure domain, where innovation and disruption are a constant driving force. Theranos' collapse has sent shockwaves through the biotech industry, with many investors and partners left reeling from the loss of their fortunes. The documentary promises to explore the practical implications of Holmes' actions, including the damage to the reputation of the biotech industry as a whole and the devastating impact on the lives of those who lost money and reputation in the wake of her company's collapse.

The collapse of Theranos has also had significant implications for the research community, which has been forced to re-evaluate its assumptions about the potential of biotech startups. The documentary promises to explore the complex interplay between innovation and regulation, highlighting the challenges faced by researchers and entrepreneurs who seek to bring new technologies to market. For many professionals in the Global Infrastructure domain, the stakes are high, and the consequences of failure can be catastrophic.

Holmes' story is part of a larger narrative that explores the complex interplay between innovation, disruption, and regulation in the tech world. The rise of biotech startups in the early 2010s was marked by a wave of innovation and disruption, with companies like Theranos promising to revolutionize the healthcare industry with their proprietary technologies. However, this period of innovation was also marked by a series of cautionary tales, including the collapse of companies like Theranos and the rise of regulatory bodies like the Securities and Exchange Commission (SEC), which has been tasked with policing the activities of biotech startups.